Sekisui Chemical (TSE:4204) Updates Guidance As Fair Value Debate Stays Open
Sekisui Chemical (TSE:4204) updated its outlook on 31 July 2026, issuing revised guidance for the first half of fiscal 2026 and new full year targets that clarify expected sales, profit and earnings per share.
See our latest analysis for Sekisui Chemical.
The updated guidance has landed after a period of building momentum for Sekisui Chemical, with a 13.82% 90 day share price return and a 5 year total shareholder return of 64.29% signaling improving sentiment around the longer term story.
If the guidance update has you thinking about where else to find potential growth tied to infrastructure spending, this can be a useful moment to scan 37 power grid technology and infrastructure stocks
Bulls see Sekisui Chemical’s guidance and recent share price strength as confirmation of a solid infrastructure and housing story. Bears point to raw material pressures and a modest value score. Which case does the valuation support next?
Most Popular Narrative: 3.2% Overvalued
Sekisui Chemical last closed at ¥2,689, which sits slightly above the most widely followed fair value estimate of ¥2,606 that applies a 5.43% discount rate and detailed long term forecasts.
Expansion of high-value-added housing products, including increasing unit prices through solar/storage battery adoption and premium apartment buildings, positions Sekisui Chemical to benefit from growing global demand for sustainable and energy-efficient homes, potentially accelerating revenue growth and boosting operating margins. Ongoing investments in perovskite solar cell capacity and modular construction technology prepare the company to capitalize on increased sustainability standards and urbanization trends, supporting future sales and long-term margin improvement as demand for advanced building materials rises.
Curious what kind of revenue path, margin lift and future earnings multiple that fair value assumes. The narrative leans on specific housing, materials and healthcare projections that could materially reshape Sekisui Chemical’s profit mix over the coming years.
Result: Fair Value of ¥2,606 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Sekisui Chemical still faces pressure from a sluggish domestic housing market and currency swings that can quickly alter earnings power and sentiment around the stock.
Find out about the key risks to this Sekisui Chemical narrative.
Another View on Sekisui Chemical’s Value
The analyst narrative frames Sekisui Chemical as 3.2% overvalued against a fair value of ¥2,606. Our DCF model tells a slightly different story. On this view, the stock at ¥2,689 sits about 4.2% below an estimated future cash flow value of roughly ¥2,808. Which signal do you put more weight on as guidance evolves?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Sekisui Chemical for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 19 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With sentiment on Sekisui Chemical clearly mixed, now is a good time to move fast, look through the data and stress test your own thesis using the 3 key rewards and 1 important warning sign
Looking for more investment ideas beyond Sekisui Chemical?
If you stop with Sekisui Chemical, you could miss other opportunities. Use this moment to broaden your watchlist with focused ideas built from clear fundamentals.
- Target resilient cash generators with reliable fundamentals through the 19 high quality undervalued stocks.
- Strengthen your income focus by scanning companies that qualify for the 42 dividend fortresses.
- Balance return potential with stability by shortlisting candidates from the 55 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com